The company expired its plan on June 23, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+35.01% | 709B | |
+30.53% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.55% | 239B | |
+9.34% | 211B | |
-3.76% | 203B | |
+10.77% | 171B |